Ji‐Yoon Ryu

562 total citations
17 papers, 486 citations indexed

About

Ji‐Yoon Ryu is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Ji‐Yoon Ryu has authored 17 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Reproductive Medicine. Recurrent topics in Ji‐Yoon Ryu's work include Ovarian cancer diagnosis and treatment (4 papers), Cancer Mechanisms and Therapy (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Ji‐Yoon Ryu is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Cancer Mechanisms and Therapy (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Ji‐Yoon Ryu collaborates with scholars based in South Korea, United States and Nepal. Ji‐Yoon Ryu's co-authors include Eun-Ju Chang, Hao Huang, Hong‐Hee Kim, Zang Hee Lee, Youngkyun Lee, Young‐Jae Cho, Jeong‐Won Lee, Jung‐Joo Choi, Chel Hun Choi and Duk‐Soo Bae and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Ji‐Yoon Ryu

17 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ji‐Yoon Ryu South Korea	10	324	180	84	49	49	17	486
Stephanie Annett Ireland	12	252 0.8×	169 0.9×	98 1.2×	48 1.0×	58 1.2×	16	495
Changhao Liu China	15	366 1.1×	110 0.6×	204 2.4×	68 1.4×	55 1.1×	46	682
Jianming Huang China	13	211 0.7×	106 0.6×	128 1.5×	36 0.7×	90 1.8×	41	450
Dongyi Wan China	10	326 1.0×	153 0.8×	146 1.7×	44 0.9×	37 0.8×	16	481
Laura Mannarino Italy	10	214 0.7×	188 1.0×	104 1.2×	120 2.4×	119 2.4×	24	498
Beibei Liu China	13	477 1.5×	164 0.9×	225 2.7×	51 1.0×	65 1.3×	46	711
Xiaoping He United States	10	327 1.0×	255 1.4×	111 1.3×	40 0.8×	35 0.7×	28	560
Rosalie Joosten Netherlands	9	279 0.9×	261 1.4×	104 1.2×	28 0.6×	85 1.7×	13	528
Tadashi Hayasaka Japan	8	287 0.9×	185 1.0×	129 1.5×	29 0.6×	56 1.1×	16	511

Countries citing papers authored by Ji‐Yoon Ryu

Since Specialization

Citations

This map shows the geographic impact of Ji‐Yoon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Yoon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Yoon Ryu more than expected).

Fields of papers citing papers by Ji‐Yoon Ryu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji‐Yoon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Yoon Ryu. The network helps show where Ji‐Yoon Ryu may publish in the future.

Co-authorship network of co-authors of Ji‐Yoon Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Ji‐Yoon Ryu. A scholar is included among the top collaborators of Ji‐Yoon Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji‐Yoon Ryu. Ji‐Yoon Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lee, Yoo-Young, Ji‐Yoon Ryu, Young‐Jae Cho, et al.. (2024). The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression. Cancer Cell International. 24(1). 43–43. 3 indexed citations

Hwang, Jae Ryoung, Young‐Jae Cho, Ji‐Yoon Ryu, et al.. (2023). Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma. Biomedicine & Pharmacotherapy. 168. 115792–115792. 2 indexed citations

Ryu, Ji‐Yoon, Jung‐Joo Choi, Jae Ryoung Hwang, et al.. (2023). Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer. Journal of Gynecologic Oncology. 34(5). e58–e58. 11 indexed citations

Noh, Joseph J., Young‐Jae Cho, Ji‐Yoon Ryu, et al.. (2022). Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma. Clinical Cancer Research. 28(17). 3850–3861. 3 indexed citations

Ryu, Ji‐Yoon, Jiyoung Oh, Hana Jeong, et al.. (2022). SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells. BMB Reports. 55(4). 198–203. 7 indexed citations

Jeong, Soo, Young‐Jae Cho, Ji‐Yoon Ryu, et al.. (2021). Establishment and preclinical application of a patient-derived xenograft model for uterine cancer. Gynecologic Oncology. 162(1). 173–181. 7 indexed citations

Hwang, Jae Ryoung, Woo Young Kim, Young‐Jae Cho, et al.. (2020). Chloroquine reverses chemoresistance via upregulation of p21WAF1/CIP1 and autophagy inhibition in ovarian cancer. Cell Death and Disease. 11(12). 1034–1034. 50 indexed citations

Paik, E Sun, Tae Hyun Kim, Young‐Jae Cho, et al.. (2020). Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer. Scientific Reports. 10(1). 4904–4904. 21 indexed citations

Noh, Joseph J., Young‐Jae Cho, Yoo-Young Lee, et al.. (2020). Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer. Pharmaceutics. 12(10). 987–987. 6 indexed citations

10.

Kim, Jihye, Young‐Jae Cho, Ji‐Yoon Ryu, et al.. (2019). CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer. Gynecologic Oncology. 156(1). 211–221. 22 indexed citations

11.

Lee, Yoo-Young, Young‐Jae Cho, Sung-Won Shin, et al.. (2019). Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer. Scientific Reports. 9(1). 15394–15394. 38 indexed citations

12.

Choi, Chel Hun, Ji‐Yoon Ryu, Young‐Jae Cho, et al.. (2017). The anti-cancer effects of itraconazole in epithelial ovarian cancer. Scientific Reports. 7(1). 6552–6552. 45 indexed citations

13.

Yoon, Aera, Ji‐Yoon Ryu, Young‐Jae Cho, et al.. (2016). c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma. Scientific Reports. 6(1). 38502–38502. 34 indexed citations

14.

Lee, Jeong‐Won, Ji‐Yoon Ryu, Gun Yoon, et al.. (2014). Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer. International Journal of Cancer. 137(1). 221–229. 39 indexed citations

15.

Ryu, Ji‐Yoon, et al.. (2014). Mechanism of anti-tumor and anti-invasive function of SOCS isoform in colon cancer models. The EPMA Journal. 5(S1). 2 indexed citations

16.

Song, Ha Yong, et al.. (2007). Extracellular HIV-1 Tat enhances monocyte adhesion by up-regulation of ICAM-1 and VCAM-1 gene expression via ROS-dependent NF-κB activation in astrocytes. Experimental & Molecular Medicine. 39(1). 27–37. 46 indexed citations

17.

Huang, Hao, Eun-Ju Chang, Ji‐Yoon Ryu, et al.. (2006). Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochemical and Biophysical Research Communications. 351(1). 99–105. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact